Annual Net Income
-$20.83 M
+$2.94 M+12.38%
December 31, 2023
Summary
- As of February 7, 2025, CRDL annual net profit is -$20.83 million, with the most recent change of +$2.94 million (+12.38%) on December 31, 2023.
- During the last 3 years, CRDL annual net income has fallen by -$5.43 million (-35.22%).
- CRDL annual net income is now -1525.45% below its all-time high of -$1.28 million, reached on December 1, 2017.
Performance
CRDL Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$9.33 M
-$4.51 M-93.69%
September 30, 2024
Summary
- As of February 7, 2025, CRDL quarterly net profit is -$9.33 million, with the most recent change of -$4.51 million (-93.69%) on September 30, 2024.
- Over the past year, CRDL quarterly net income has dropped by -$4.51 million (-93.69%).
- CRDL quarterly net income is now -2082.34% below its all-time high of -$427.40 thousand, reached on September 1, 2017.
Performance
CRDL Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$26.56 M
-$4.91 M-22.67%
September 30, 2024
Summary
- As of February 7, 2025, CRDL TTM net profit is -$26.56 million, with the most recent change of -$4.91 million (-22.67%) on September 30, 2024.
- Over the past year, CRDL TTM net income has dropped by -$4.91 million (-22.67%).
- CRDL TTM net income is now -6114.04% below its all-time high of -$427.40 thousand, reached on September 1, 2017.
Performance
CRDL TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
CRDL Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +12.4% | -93.7% | -22.7% |
| 3 y3 years | -35.2% | -93.7% | -22.7% |
| 5 y5 years | -69.8% | -93.7% | -22.7% |
CRDL Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +17.4% | -111.1% | at low | -28.0% | at low |
| 5 y | 5-year | -102.0% | +17.4% | -324.1% | at low | -171.7% | +4.0% |
| alltime | all time | -1525.5% | +17.4% | -2082.3% | at low | -6114.0% | +4.0% |
Cardiol Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$9.33 M(+93.7%) | -$26.56 M(+22.7%) |
| Jun 2024 | - | -$4.82 M(-29.2%) | -$21.65 M(-3.3%) |
| Mar 2024 | - | -$6.81 M(+21.3%) | -$22.39 M(+7.5%) |
| Dec 2023 | -$20.83 M(-12.4%) | -$5.61 M(+27.0%) | -$20.82 M(+0.4%) |
| Sep 2023 | - | -$4.42 M(-20.4%) | -$20.75 M(-7.5%) |
| Jun 2023 | - | -$5.55 M(+6.0%) | -$22.43 M(+2.2%) |
| Mar 2023 | - | -$5.24 M(-5.3%) | -$21.96 M(-7.7%) |
| Dec 2022 | -$23.77 M(-5.8%) | -$5.53 M(-9.4%) | -$23.78 M(+2.4%) |
| Sep 2022 | - | -$6.11 M(+20.2%) | -$23.21 M(-7.1%) |
| Jun 2022 | - | -$5.08 M(-28.1%) | -$24.98 M(-1.0%) |
| Mar 2022 | - | -$7.07 M(+42.3%) | -$25.24 M(+0.1%) |
| Dec 2021 | -$25.24 M | - | - |
| Dec 2021 | - | -$4.96 M(-36.9%) | -$25.20 M(-8.9%) |
| Sep 2021 | - | -$7.87 M(+47.3%) | -$27.66 M(+19.8%) |
| Jun 2021 | - | -$5.34 M(-24.0%) | -$23.09 M(+13.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$7.03 M(-5.2%) | -$20.36 M(+31.1%) |
| Dec 2020 | -$15.41 M(+49.4%) | -$7.42 M(+124.6%) | -$15.53 M(+48.9%) |
| Sep 2020 | - | -$3.30 M(+26.3%) | -$10.43 M(+6.7%) |
| Jun 2020 | - | -$2.61 M(+18.9%) | -$9.77 M(-1.1%) |
| Mar 2020 | - | -$2.20 M(-5.1%) | -$9.88 M(-4.1%) |
| Dec 2019 | -$10.31 M(-15.9%) | -$2.32 M(-12.3%) | -$10.31 M(-30.6%) |
| Sep 2019 | - | -$2.64 M(-2.9%) | -$14.85 M(-7.0%) |
| Jun 2019 | - | -$2.72 M(+3.7%) | -$15.96 M(+11.7%) |
| Mar 2019 | - | -$2.62 M(-61.8%) | -$14.29 M(+18.1%) |
| Dec 2018 | -$12.26 M(+857.0%) | -$6.86 M(+82.7%) | -$12.11 M(+112.1%) |
| Sep 2018 | - | -$3.76 M(+256.8%) | -$5.71 M(+139.9%) |
| Jun 2018 | - | -$1.05 M(+141.0%) | -$2.38 M(+79.3%) |
| Mar 2018 | - | -$436.80 K(-5.6%) | -$1.33 M(+49.1%) |
| Dec 2017 | -$1.28 M | -$462.50 K(+8.2%) | -$889.90 K(+108.2%) |
| Sep 2017 | - | -$427.40 K | -$427.40 K |
FAQ
- What is Cardiol Therapeutics annual net profit?
- What is the all time high annual net income for Cardiol Therapeutics?
- What is Cardiol Therapeutics annual net income year-on-year change?
- What is Cardiol Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Cardiol Therapeutics?
- What is Cardiol Therapeutics quarterly net income year-on-year change?
- What is Cardiol Therapeutics TTM net profit?
- What is the all time high TTM net income for Cardiol Therapeutics?
- What is Cardiol Therapeutics TTM net income year-on-year change?
What is Cardiol Therapeutics annual net profit?
The current annual net income of CRDL is -$20.83 M
What is the all time high annual net income for Cardiol Therapeutics?
Cardiol Therapeutics all-time high annual net profit is -$1.28 M
What is Cardiol Therapeutics annual net income year-on-year change?
Over the past year, CRDL annual net profit has changed by +$2.94 M (+12.38%)
What is Cardiol Therapeutics quarterly net profit?
The current quarterly net income of CRDL is -$9.33 M
What is the all time high quarterly net income for Cardiol Therapeutics?
Cardiol Therapeutics all-time high quarterly net profit is -$427.40 K
What is Cardiol Therapeutics quarterly net income year-on-year change?
Over the past year, CRDL quarterly net profit has changed by -$4.51 M (-93.69%)
What is Cardiol Therapeutics TTM net profit?
The current TTM net income of CRDL is -$26.56 M
What is the all time high TTM net income for Cardiol Therapeutics?
Cardiol Therapeutics all-time high TTM net profit is -$427.40 K
What is Cardiol Therapeutics TTM net income year-on-year change?
Over the past year, CRDL TTM net profit has changed by -$4.91 M (-22.67%)